Live cultures are more commonly being used in beverages, dairy products, powders, bars and many other functional food formats. For manufacturers, the challenge is not simply adding a culture; it is maintaining its identity, viability and intended benefit through processing, storage and consumption.
A key 2026 development is the ISAPP consensus work defining the science behind gut health as the presence of normal GI functioning without active disease and symptoms affecting quality of life. This reinforces the need for evidence-led functional food development that connects strain, viable dose, food matrix, processing conditions and product performance.
Dr Radhika Ganesan, R.D., PhD, Head of Regulatory Affairs & Nutrition Science, Food Research Lab
15+ years of experience in functional food and nutraceutical formulation, including strain selection, stability engineering, and FSSAI/FDA claim substantiation.
Functional food innovation has brought probiotics into the mainstream as food ingredients through consumer interest in gut health, immunity, and metabolism. Probiotic ingredients in food are live microorganisms that are well characterised, taken at an appropriate dosage, and linked to a health claim. Functional food product development relies on evidence-driven strain selection, compatibility with the food matrix, shelf-life viability, and regulatory compliance.
Live cultures are more commonly being used in beverages, dairy products, powders, bars and many other functional food formats. For manufacturers, the challenge is not simply adding a culture; it is maintaining its identity, viability and intended benefit through processing, storage and consumption.
A key 2026 development is the ISAPP consensus work defining the science behind gut health as the presence of normal GI functioning without active disease and symptoms affecting quality of life. This reinforces the need for evidence-led functional food development that connects strain, viable dose, food matrix, processing conditions and product performance.
The probiotic ingredients in food are live microorganisms which, when administered in adequate amounts, produce health benefits on the host. Their selection needs proper characterization as well as strain-specific evidence and intended dose and food application considerations. [1]
Fermentation cultures are not automatically considered probiotics. ISAPP differentiates microorganisms that are used in fermented foods as distinct from probiotics since they can be regarded as probiotics only when they meet all scientific requirements, including defined strain identity, the appropriate amount and evidence of health benefits. [2] FSSAI explains that commonly used starter cultures in fermented milk (dahi) and similar food products cannot be called probiotics unless their probiotic characteristics have been substantiated.
For food formulation, manufacturers should therefore consider strain identity, demonstrated benefit, effective dose and compatibility with the intended food matrix together.
Health effects have been studied with probiotics for a variety of health outcomes. There is research done with respect to digestive health and immunity support, while certain strains are also being studied for their potential effect on metabolism and other health outcomes. The benefits of probiotics are strain-, dose-, formulation-, and evidence-supporting. [4]
Key Areas of Probiotic Benefits
Combining prebiotics and probiotics may be appropriate where the selected organism and substrate are compatible. Manufacturers should evaluate gut health ingredients through both a formulation and evidence perspective rather than relying on the probiotic category alone.
For functional food product development, the intended benefit should guide strain selection, dose and matrix design. Health claims should remain aligned with the evidence available for the specific strain and product.
Common probiotic strains for food products include organisms belonging to the Lactobacillus and Bifidobacterium groups, as well as organisms like Streptococcus thermophilus and Saccharomyces boulardii. A few former Lactobacillus species are now classified in genera such as Lacticaseibacillus, Lactiplantibacillus and Limosilactobacillus.
Spore-forming organisms like Bacillus coagulans can offer greater processing and storage stability in the appropriate format, but efficacy is strain-dependent. Strain selection must consider effectiveness, process stability, matrix compatibility and necessary live cell counts at the end of the product shelf life. [3]
Figure 1: Title: Strain Selection: Designing Backwards from the Health Benefit
Source: Kallur et al. (2025). Formulation-led probiotic strain selection based on the intended benefit, dose and food matrix. Immune-support evidence is strain-specific to Bacillus coagulans LMG S-31876.
Table 1 — Representative FSSAI Schedule VII microorganisms and food formats
Microorganism group | Representative organisms | Example food formats |
Lactobacillus group | L. acidophilus, L. rhamnosus, L. plantarum | Fermented dairy, chilled drinks |
Bifidobacterium | B. lactis, B. longum, B. bifidum | Yoghurt, cultured beverages |
Bacillus | B. coagulans | Bars, powders, ambient formats |
Saccharomyces | S. boulardii | Sachets, functional formats |
What Challenges Affect Probiotic Stability in Food?
The primary formulation challenge is to keep the cultures viable throughout the shelf-life period.
Microencapsulation of probiotics using food-compatible systems such as alginate or pectin can provide additional physical protection in suitable applications. Spore-forming strains can also offer greater robustness in selected formulations. [5]
Figure 2 Title: Effect of Microencapsulation on Probiotic Viability During Storage
Encapsulation improved Bifidobacterium bifidum viability in cheddar cheese over 35 days at 4°C. Data from Afzaal et al. (2020) were discussed in Nikitina & Khrundin (2026).
Do not formulate to the day-one count. Build from the required consumption dose, add a validated overage for losses, and confirm strain–matrix compatibility in the final pack. Shelf-life data — not initial CFU — drives the target, especially for shelf-stable probiotics.
In India, FSSAI prescribes a minimum of ≥10⁸ CFU in the recommended daily serving of foods containing added probiotics. Lower concentrations could be accepted on the grounds of proven health benefits with prior approval. The food label must disclose the name of the microorganism genus, species, and strain, viable count, serving size, and storage instructions. Schedule VII outlines the eligible probiotic microorganisms, and they must be non-GMO. [6]
Figure 3: Source: Food Safety and Standards Authority of India. (2021). Compendium of regulations relating to nutraceuticals, functional foods, etc
For the European Union, health claims must be scientifically substantiated and authorised under the applicable EU framework. EFSA evaluates the scientific evidence, while the European Commission and Member States determine authorisation. Manufacturers should check the EU Register of Health Claims for the authorised claim wording, conditions of use and applicable restrictions, and conduct a market-specific regulatory review before finalising claims and artwork. [7]
Table 2 — Core viability and labelling checkpoints for India
Requirement | India / FSSAI | Practical formulation action |
Minimum viable count | ≥10⁸ CFU / recommended daily serving | Establish overage from stability data |
Strain eligibility | Relevant Schedule VII organisms | Confirm identity and regulatory status |
Label declaration | Genus, species, strain, EOL count, serving size, storage | Finalise artwork after review |
Health claims | Applicable substantiation and labelling | Maintain evidence documentation |
Brief: A beverage client required a probiotic fruit drink to maintain the desired viable dose without refrigeration – a challenging low-pH, high-moisture environment for living microorganisms.
Approach: FRL identified the strain-matrix compatibility, selected an appropriate strain of Bacillus coagulans, added the right prebiotic fibre and developed the formulation and packaging; followed by viability testing under real-time and accelerated conditions
≥10⁸ CFU per serving retained over 9-month shelf life
Formulation designed for ambient distribution
Strain and labelling were compliant with relevant FSSAI regulations
Viability validated in the final product and package
Key takeaway: FRL developed backwards based on the end-of-shelf-life viability dosage rather than the initial CFU dosage.
Successful functional food probiotic development requires the right strain, matrix, process and shelf-life strategy working together. This alignment allows for creating probiotic ingredients in food that can be developed into evidence-led products with defined quality and regulatory requirements.
Ready to develop your next functional food product? Partner with Food Research Lab for end-to-end functional food product development — from ingredient and strain selection to formulation, process optimisation, shelf-life validation and regulatory support.
Probiotic ingredients are live microorganisms providing a proven health benefit when taken at an adequate quantity. Common examples include Lactobacillus and Bifidobacterium strains.
Probiotic-fortified foods may help in attaining specific digestive and immune benefits, depending on the strain, formula and dose used. Some other benefits have yet to be scientifically validated.
Manufacturers use suitable processing, microencapsulation, packaging and storage controls to maintain probiotic viability throughout shelf life.
Yes. Claims must meet target-market requirements and be supported by appropriate evidence, including strain identity, viable count, dose and substantiation.
Get a free packaging compliance review within 24 hours.
Food Research Lab strives for excellence in new Food, Beverage and Nutraceutical Product Research and Development by offering cutting edge scientific analysis and expertise.